PitchSend

Investor Presentaiton

NZ$ Millions New Zealand benefits from fewer restrictions New Zealand total revenue $35.0 $30.1 $30.5 1H $30.0 $27.1 $26.8 $25.0 $20.0 $15.0 $10.0 $5.0 $0.0 $15.8 15% $13.7 FY2018 FY 2019 FY2020 FY2021 1H FY22 New Zealand channel 17% 16% 29% 29% 1H 2021 55% 54% ■ ОТС Prescription ■ Hospital 1H 2022 • Growth led by the OTC channel (up 13%) and reflects a period of more normal trading, with Vitamin C Liposachets and Maxigesic leading growth • The hospital channel grew 23% lifted by antibiotic sales • The prescription channel grew 15% with the return to a period of more normal activity AFTpharmaceuticals Page 7

View entire presentation